This page lists the SEC filings reported by VIKING GLOBAL INVESTORS LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-03-20 | VIKING GLOBAL INVESTORS LP | STANDARD BIOTOOLS INC. | 58,651,170 | 15.3% | EDGAR |
| SC 13G/A | 2024-03-01 | VIKING GLOBAL INVESTORS LP | APi Group Corp | 32,022,915 | 12.3% | EDGAR |
| SC 13G/A | 2024-02-28 | VIKING GLOBAL INVESTORS LP | RayzeBio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Five9, Inc. | 2,714,117 | 3.7% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | NewAmsterdam Pharma Co N.V. | 8,024,565 | 9.7% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Viking Therapeutics, Inc. | 5,145,112 | 5.1% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | VALVOLINE INC | 3,176,309 | 2.4% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Ginkgo Bioworks Holdings, Inc. | 143,085,126 | 8.8% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | PepGen Inc. | 1,482,434 | 6.2% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Rallybio Corp | 4,194,777 | 11.1% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Roivant Sciences Ltd. | 69,368,961 | 8.6% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Trevi Therapeutics, Inc. | 6,599,062 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Adaptive Biotechnologies Corp | 29,993,708 | 20.7% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Amylyx Pharmaceuticals, Inc. | 2,962,555 | 4.4% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | APi Group Corp | 42,517,157 | 17.4% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Edgewise Therapeutics, Inc. | 6,159,146 | 9.7% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Pharvaris N.V. | 3,656,923 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Inhibrx, Inc. | 7,150,826 | 15.1% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Verastem, Inc. | 2,531,829 | 10.0% | EDGAR |
| SC 13D/A | 2024-02-05 | VIKING GLOBAL INVESTORS LP | Cazoo Group Ltd | 2,142,728 | 43.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.